Browse

Recurrent Fusion Transcripts Detected by Whole-transcriptome Sequencing of 120 Primary Breast Cancer Samples
120개 유방암 조직의 차세대 염기서열 분석을 통한 융합 전사체 발굴

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors
김지선, 김세환, 고세윤, 인용호, 문형곤, 안수경, 김민균, 이민주, 황진하, 주영석, 김종일, 노동영, 김선, 박정훈, 이환석, 김성훈, 한원식
Advisor
한원식
Major
의과대학 의학과
Issue Date
2015-08
Publisher
서울대학교 대학원
Keywords
Fusion geneFusion transcriptWhole transcriptome sequencingRNA-SeqBreast cancer
Description
학위논문 (박사)-- 서울대학교 대학원 : 의학과 외과학전공, 2015. 8. 한원식.
Abstract
Purpose: Although fusion genes serve as an effective target in hematologic malignancies, recurrent gene fusion events are relatively rare in solid tumors. To detect recurrent novel fusion transcripts we performed whole transcriptome sequencing primary breast cancer samples.
Experimental Design: Whole-transcriptome sequencing of 120 fresh-frozen primary breast cancer samples and five adjacent normal breast tissues using the Illumina HiSeq2000 platform was performed. Three different fusion-detecting tools (deFuse, Chimerascan, and TopHat) were used, and the results were compared.
Results: These tools detected 3831, 6630 and 516 fusion transcripts (FTs) overall. We primarily focused on the results obtained using the deFuse software. More FTs were identified from HER2 subtype breast cancer samples than from the luminal or triple-negative subtypes (p < 0.05). Seventy fusion candidates were selected for validation, and 32 (45.7%) were confirmed by RT-PCR and Sanger sequencing. Of the validated fusions, six were recurrent (found in 2 or more samples), three were in-frame (PRDX1-AKR1A1, TACSTD2-OMA1 and C2CD2-TFF1) and three were off-frame (CEACAM7-CEACAM6, CYP4X1-CYP4Z2P, and EEF1DP3-FRY). Notably, the novel read-through fusion, EEF1DP3-FRY, was identified and validated in 6.7% (8/120) of the breast cancer samples. This off-frame fusion results in early truncation of the FRY gene, which plays a key role in the structural integrity during mitosis. Three previously reported fusions, PPP1R1B-STARD3, MFGE8-HAPL, and ETV6-NTRK3, were detected in 8.3%, 3.3% and 0.8% of the 120 samples, respectively, by both deFuse and Chimerascan. The recently reported MAGI3-AKT3 fusion was not detected in our analysis.
Conclusion: Among the 3800s fusions detected by mRNA Sequencing, 32 fusions were validated using Sanger sequencing, including the novel recurrent read-through fusion, EEF1DP3-FRY. Previously reported FTs, such as PPP1R1B-STARD3, MFGE8-HAPLN3 and ETV6-NTRK3, were also identified. Future work is warranted to elucidate the biological significance of these fusions.
Language
English
URI
https://hdl.handle.net/10371/122075
Files in This Item:
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Dept. of Medicine (의학과)Theses (Ph.D. / Sc.D._의학과)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse